240 related articles for article (PubMed ID: 10964826)
1. Clinical efficacy of the polyurethane stent without fluoroscopic guidance in the treatment of nasolacrimal duct obstruction.
Lee JS; Jung G; Oum BS; Lee SH; Roh HJ
Ophthalmology; 2000 Sep; 107(9):1666-70. PubMed ID: 10964826
[TBL] [Abstract][Full Text] [Related]
2. Treatment of nasolacrimal duct obstruction in adults with polyurethane stent.
Yazici B; Yazici Z; Parlak M
Am J Ophthalmol; 2001 Jan; 131(1):37-43. PubMed ID: 11162977
[TBL] [Abstract][Full Text] [Related]
3. Treatment of complete and partial obstruction of the nasolacrimal system with polyurethane stents: initial experience.
Pulido-Duque JM; Reyes R; Carreira JM; Vega F; Górriz E; Pardo MD; Perez F; Maynar M
Cardiovasc Intervent Radiol; 1998; 21(1):41-4. PubMed ID: 9473545
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with nasolacrimal polyurethane stent implantation: do they keep tearing?
Oztürk S; Konuk O; Ilgit ET; Unal M; Erdem O
Ophthalmic Plast Reconstr Surg; 2004 Mar; 20(2):130-5. PubMed ID: 15083082
[TBL] [Abstract][Full Text] [Related]
5. Nasolacrimal polyurethane stent placement: preliminary results.
Perena MF; Castillo J; Medrano J; De Gregorio MA; Loras E; Cristobal JA
Eur J Ophthalmol; 2001; 11(1):25-30. PubMed ID: 11284481
[TBL] [Abstract][Full Text] [Related]
6. The polyurethane nasolacrimal duct stent for lower tear duct obstruction: long-term success rate and complications.
Schaudig U; Maas R
Graefes Arch Clin Exp Ophthalmol; 2000 Sep; 238(9):733-7. PubMed ID: 11045340
[TBL] [Abstract][Full Text] [Related]
7. Treatment of nasolacrimal duct obstruction with polyurethane stent placement: long-term results.
Yazici Z; Yazici B; Parlak M; Tuncel E; Ertürk H
AJR Am J Roentgenol; 2002 Aug; 179(2):491-4. PubMed ID: 12130461
[TBL] [Abstract][Full Text] [Related]
8. Treatment of complete obstruction of the nasolacrimal system by temporary placement of nasolacrimal polyurethane stents: preliminary results.
Paúl L; Pinto I; Vicente JM
Clin Radiol; 2003 Nov; 58(11):876-82. PubMed ID: 14581012
[TBL] [Abstract][Full Text] [Related]
9. [Nasolacrimal stent implantation: report of a case].
Lunardelli P; Aoki L; Jervásio AC; Zagui RM; Matayoshi S
Arq Bras Oftalmol; 2008; 71(1):110-4. PubMed ID: 18408851
[TBL] [Abstract][Full Text] [Related]
10. Nasolacrimal polyurethane stent: complications with CT correlation.
Pinto IT; Paul L; Grande C
Cardiovasc Intervent Radiol; 1998; 21(6):450-3. PubMed ID: 9853160
[TBL] [Abstract][Full Text] [Related]
11. Nonsurgical placement of a nasolacrimal polyurethane stent: long-term effectiveness.
Song HY; Jin YH; Kim JH; Suh SW; Yoon HK; Kang SG; Sung KB
Radiology; 1996 Sep; 200(3):759-63. PubMed ID: 8756928
[TBL] [Abstract][Full Text] [Related]
12. Management of functional epiphora in patients with an anatomically patent dacryocystorhinostomy.
Shams PN; Chen PG; Wormald PJ; Sloan B; Wilcsek G; McNab A; Selva D
JAMA Ophthalmol; 2014 Sep; 132(9):1127-32. PubMed ID: 24903661
[TBL] [Abstract][Full Text] [Related]
13. Nonsurgical placement of a nasolacrimal polyurethane stent.
Song HY; Jin YH; Kim JH; Huh SJ; Kim YH; Kim TH; Sung KB
Radiology; 1995 Jan; 194(1):233-7. PubMed ID: 7997560
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic findings after nasolacrimal polyurethane stent implantations.
Lee JH; Kang MS; Yang JW
Korean J Ophthalmol; 2005 Dec; 19(4):252-7. PubMed ID: 16491813
[TBL] [Abstract][Full Text] [Related]
15. [Nasolacrimal stent for epiphora caused by obstruction of the nasolacrimal duct].
Posthuma BJ; van Imhoff WL; van Wezer JE
Ned Tijdschr Geneeskd; 1997 Feb; 141(7):339-41. PubMed ID: 9132609
[TBL] [Abstract][Full Text] [Related]
16. Long-term results and factors affecting patency after removal of nasolacrimal stents.
Kim JH; Shin JH; Song HY; Kang W; Lim JO; Park SH; Ko GY; Yoon HK; Sung KB
J Vasc Interv Radiol; 2006 Jul; 17(7):1125-30. PubMed ID: 16868165
[TBL] [Abstract][Full Text] [Related]
17. [A comparative study of lacrimal magnetic resonance hydrography and lacrimal endoscopy examination in the diagnosis and treatment of lacrimal duct obstructive diseases].
Xiang N; Liu R; Zhang SJ; Hu WK; Zhan XY; Luo B; Ai T
Zhonghua Yan Ke Za Zhi; 2016 Feb; 52(2):117-22. PubMed ID: 26906707
[TBL] [Abstract][Full Text] [Related]
18. Nasolacrimal stents in the management of epiphora: medium-term results of a multicenter prospective study.
Lanciego C; De Miguel S; Perea M; Cano C; García IR; Dávila J; Ibarburen C; Toledano N; Rodriguez-Merlo R; García LG
J Vasc Interv Radiol; 2001 Jun; 12(6):701-10. PubMed ID: 11389221
[TBL] [Abstract][Full Text] [Related]
19. Nasolacrimal duct obstruction treated nonsurgically with use of plastic stents.
Song HY; Jin YH; Kim JH; Sung KB; Han YM; Cho NC
Radiology; 1994 Feb; 190(2):535-9. PubMed ID: 8284412
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of polyurethane stent implantation for the treatment of complete obstruction of the nasolacrimal system: 8-month follow-up and complications].
Anders N; Hoffmann KT; Hosten N; Walkow T; Felix R; Hartmann C
Ophthalmologe; 1999 Oct; 96(10):658-62. PubMed ID: 10552159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
